TY - JOUR
T1 - Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease
AU - for the Dominantly Inherited Alzheimer Network (DIAN)
AU - Montal, Victor
AU - Vilaplana, Eduard
AU - Pegueroles, Jordi
AU - Bejanin, Alexandre
AU - Alcolea, Daniel
AU - Carmona-Iragui, María
AU - Clarimón, Jordi
AU - Levin, Johannes
AU - Cruchaga, Carlos
AU - Graff-Radford, Neill R.
AU - Noble, James M.
AU - Lee, Jae Hong
AU - Allegri, Ricardo
AU - Karch, Celeste M.
AU - Laske, Christoph
AU - Schofield, Peter R.
AU - Salloway, Stephen
AU - Ances, Beau
AU - Benzinger, Tammie
AU - McDale, Eric
AU - Bateman, Randall
AU - Blesa, Rafael
AU - Sánchez-Valle, Raquel
AU - Lleó, Alberto
AU - Fortea, Juan
N1 - Publisher Copyright:
© 2020 the Alzheimer's Association
PY - 2021/4
Y1 - 2021/4
N2 - INTRODUCTION: A biphasic model for brain structural changes in preclinical Alzheimer's disease (AD) could reconcile some conflicting and paradoxical findings in observational studies and anti-amyloid clinical trials. METHODS: In this study we tested this model fitting linear versus quadratic trajectories and computed the timing of the inflection points vertexwise of cortical thickness and cortical diffusivity—a novel marker of cortical microstructure—changes in 389 participants from the Dominantly Inherited Alzheimer Network. RESULTS: In early preclinical AD, between 20 and 15 years before estimated symptom onset, we found increases in cortical thickness and decreases in cortical diffusivity followed by cortical thinning and cortical diffusivity increases in later preclinical and symptomatic stages. The inflection points 16 to 19 years before estimated symptom onset are in agreement with the start of tau biomarker alterations. DISCUSSION: These findings confirm a biphasic trajectory for brain structural changes and have direct implications when interpreting magnetic resonance imaging measures in preventive AD clinical trials.
AB - INTRODUCTION: A biphasic model for brain structural changes in preclinical Alzheimer's disease (AD) could reconcile some conflicting and paradoxical findings in observational studies and anti-amyloid clinical trials. METHODS: In this study we tested this model fitting linear versus quadratic trajectories and computed the timing of the inflection points vertexwise of cortical thickness and cortical diffusivity—a novel marker of cortical microstructure—changes in 389 participants from the Dominantly Inherited Alzheimer Network. RESULTS: In early preclinical AD, between 20 and 15 years before estimated symptom onset, we found increases in cortical thickness and decreases in cortical diffusivity followed by cortical thinning and cortical diffusivity increases in later preclinical and symptomatic stages. The inflection points 16 to 19 years before estimated symptom onset are in agreement with the start of tau biomarker alterations. DISCUSSION: These findings confirm a biphasic trajectory for brain structural changes and have direct implications when interpreting magnetic resonance imaging measures in preventive AD clinical trials.
KW - Alzheimer's disease
KW - autosomal-dominant Alzheimer's disease
KW - biphasic cortical changes
KW - cortical diffusivity
KW - magnetic resonance imaging
KW - preclinical Alzheimer's disease
UR - http://www.scopus.com/inward/record.url?scp=85096946684&partnerID=8YFLogxK
U2 - 10.1002/alz.12224
DO - 10.1002/alz.12224
M3 - Article
C2 - 33196147
AN - SCOPUS:85096946684
SN - 1552-5260
VL - 17
SP - 618
EP - 628
JO - Alzheimer's and Dementia
JF - Alzheimer's and Dementia
IS - 4
ER -